Pharmalliance SA
13.5 FTEThe score of Pharmalliance shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +46 % Total assets +69 % Headcount (avg FTE) +26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmalliance's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Aug 2026
- Year ended 31 Mar 2024filed on 02 Dec 2024
- Year ended 31 Mar 2023filed on 30 Nov 2023
- Year ended 31 Mar 2022filed on 03 Nov 2022
- Year ended 31 Mar 2021filed on 02 Nov 2021
Pharmalliance's financial analysis
- Solvency19.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmalliance
Pharmalliance's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0867.465.852
- VAT number
- BE0867465852
- Peppol
- Registered · 0208:0867465852 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Sep 2004
- Registered office
- 1380 Lasne
- Size
- Small · 13.5 FTE
- Latest accounts
- 2025 · filed on 22 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmalliance (SA) has been based in Lasne since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 43,298 € and equity of €1.25m; its revenue is not published. With 13.5 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 19.6%, below the median of its sector (41.5%).
Companies similar to Pharmalliance
Companies in the same business, of comparable size and area, outside its group.
- Peeters Pharma Retail sale of pharmaceutical products Kinrooi · balance sheet €12.1m
- Nerum Retail sale of pharmaceutical products Heusden-Zolder · balance sheet €6.46m
- Palatine Retail sale of pharmaceutical products Etterbeek · balance sheet €6.58m
- Farmathé Retail sale of pharmaceutical products Menen · balance sheet €7.37m
- Dermatheek Retail sale of pharmaceutical products Ranst · balance sheet €5.46m
- Apotheek Bourguignon-Deraeve Retail sale of pharmaceutical products Ninove · balance sheet €5.34m
- Apophar Retail sale of pharmaceutical products Ixelles · balance sheet €5.33m
- Alpaga MDB Retail sale of pharmaceutical products Kontich · balance sheet €5.32m
Frequently asked questions about Pharmalliance
What is the revenue of Pharmalliance?
Pharmalliance files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmalliance?
In Belgium, the VAT number is the company number prefixed with BE: BE0867465852 for Pharmalliance, if the company is VAT-registered. Its company number (CBE) is 0867.465.852.
Where is the registered office of Pharmalliance?
According to the CBE register, the registered office of Pharmalliance is in 1380 Lasne.
What is the equity of Pharmalliance?
At the close of the 2025 financial year, the equity of Pharmalliance amounts to 1,249,684 €, a solvency of 19.6% of total assets.
How many people work at Pharmalliance?
13.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmalliance?
The register lists 7 active mandates at Pharmalliance. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmalliance
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →